Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Study summary
T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia.
The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.
Eligibility
Primary outcome measure(s)
- Evaluate the natural course of the diabetes of obese patients over a period of 10 years — ten years
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Min-Sheng General Hospital | Taoyuan City | Taiwan | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT02166372 on ClinicalTrials.gov ↗ ← All trials in Taiwan